Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
Can J Physiol Pharmacol. 2010 Jul;88(7):702-15. doi: 10.1139/y10-055.
Earlier studies have demonstrated that ouabain-induced increase in [Ca2+]i, as a consequence of sarcolemma (SL) Na+/K+-ATPase inhibition, is associated with activation of both the SL Na+/Ca2+ exchanger and SL Ca2+ channels. In view of the importance of sarcoplasmic reticulum (SR) in the regulation of [Ca2+]i, this study examined the role of SR in ouabain-induced increase in [Ca2+]i in both quiescent and KCl-depolarized cardiomyocytes. For this purpose, adult rat cardiomyocytes were loaded with fura-2 and ouabain-induced changes in [Ca2+]i were monitored upon treatment with or without different agents that are known to influence Ca2+ handling by the intracellular organelles. Ouabain not only increased the basal [Ca2+]i and augmented KCl-induced increase in [Ca2+]i but also produced similar effects on the ATP-induced increase in [Ca2+]i. Treatments of cardiomyocytes with caffeine, ryanodine, or cyclopiazonic acid, which affect SR Ca2+ stores, attenuated the ouabain-induced increase in basal Ca2+ as well as augmentation of the KCl response. Both ryanodine and cyclopiazonic acid produced additional effects, when used in combination with a SL Ca2+ channel inhibitor (verapamil), but not with a Na+/Ca2+ exchange inhibitor (KB-R7943). Inhibitors of Ca2+/calmodulin kinase, protein kinase A, and inositol-3-phosphate receptors were also observed to depress the ouabain-induced increase in [Ca2+]i in cardiomyocytes. On the other hand, mitochondrial Ca2+ transport inhibitors did not exert any effect on the ouabain-induced alterations in [Ca2+]i in cardiomyocytes. Furthermore, ouabain did not show any direct effect on the Ca2+ uptake and Ca2+ release activities of SR or mitochondria. These results suggest an indirect involvement of SR Ca2+ stores in the ouabain-induced increase in [Ca2+]i in cardiomyocytes and indicate the participation of both Ca2+-induced Ca2+ release and regulatory mechanisms in this action.
先前的研究表明,由于肌浆网(SL)Na+/K+-ATP 酶的抑制,哇巴因诱导的[Ca2+]i 增加与 SL Na+/Ca2+交换器和 SL Ca2+通道的激活有关。鉴于肌浆网(SR)在调节[Ca2+]i 中的重要性,本研究检查了 SR 在哇巴因诱导的静息和 KCl 去极化心肌细胞中[Ca2+]i 增加中的作用。为此,用 fura-2 负载成年大鼠心肌细胞,并在使用或不使用已知影响细胞内细胞器钙处理的不同试剂处理时监测哇巴因诱导的[Ca2+]i 变化。哇巴因不仅增加了基础[Ca2+]i,并且增强了 KCl 诱导的[Ca2+]i 增加,而且对 ATP 诱导的[Ca2+]i 增加也产生了类似的影响。用咖啡因、ryanodine 或环匹阿尼酸处理心肌细胞,这些试剂影响 SR Ca2+库,减弱了哇巴因诱导的基础 Ca2+增加以及 KCl 反应的增强。Ryanodine 和环匹阿尼酸在与 SL Ca2+通道抑制剂(维拉帕米)联合使用时产生了额外的效果,但与 Na+/Ca2+交换抑制剂(KB-R7943)联合使用时没有。钙/钙调蛋白激酶、蛋白激酶 A 和肌醇-3-磷酸受体抑制剂也观察到可降低心肌细胞中哇巴因诱导的[Ca2+]i 增加。另一方面,线粒体 Ca2+转运抑制剂对心肌细胞中哇巴因诱导的[Ca2+]i 改变没有任何作用。此外,哇巴因对 SR 或线粒体的 Ca2+摄取和 Ca2+释放活性没有显示出任何直接作用。这些结果表明 SR Ca2+库间接参与了心肌细胞中哇巴因诱导的[Ca2+]i 增加,并表明 Ca2+-诱导的 Ca2+释放和调节机制都参与了这种作用。